Jennison Associates
REGN icon

Jennison Associates’s Regeneron Pharmaceuticals REGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-99,802
Closed -$105M 625
2024
Q2
$105M Buy
99,802
+66,281
+198% +$69.7M 0.07% 119
2024
Q1
$32.3M Buy
+33,521
New +$32.3M 0.02% 284
2023
Q2
Sell
-28,090
Closed -$23.1M 616
2023
Q1
$23.1M Buy
+28,090
New +$23.1M 0.02% 311
2021
Q4
Sell
-1,805
Closed -$1.09M 715
2021
Q3
$1.09M Buy
+1,805
New +$1.09M ﹤0.01% 597
2021
Q2
Sell
-10,061
Closed -$4.76M 713
2021
Q1
$4.76M Buy
+10,061
New +$4.76M ﹤0.01% 475
2020
Q4
Sell
-66,884
Closed -$37.4M 680
2020
Q3
$37.4M Sell
66,884
-1,673
-2% -$937K 0.03% 226
2020
Q2
$42.8M Buy
68,557
+22,157
+48% +$13.8M 0.04% 190
2020
Q1
$22.7M Buy
+46,400
New +$22.7M 0.03% 239
2019
Q3
Sell
-3,332
Closed -$1.04M 678
2019
Q2
$1.04M Sell
3,332
-83
-2% -$26K ﹤0.01% 549
2019
Q1
$1.4M Buy
+3,415
New +$1.4M ﹤0.01% 515
2018
Q2
Sell
-88,815
Closed -$30.6M 700
2018
Q1
$30.6M Buy
88,815
+13,022
+17% +$4.48M 0.03% 331
2017
Q4
$28.5M Sell
75,793
-1,123,954
-94% -$423M 0.03% 344
2017
Q3
$536M Sell
1,199,747
-93,116
-7% -$41.6M 0.55% 47
2017
Q2
$635M Buy
1,292,863
+532,547
+70% +$262M 0.67% 41
2017
Q1
$295M Sell
760,316
-1,156,625
-60% -$448M 0.32% 55
2016
Q4
$704M Sell
1,916,941
-205,207
-10% -$75.3M 0.79% 33
2016
Q3
$853M Buy
2,122,148
+91,223
+4% +$36.7M 0.92% 32
2016
Q2
$709M Sell
2,030,925
-20,934
-1% -$7.31M 0.78% 35
2016
Q1
$740M Buy
2,051,859
+35,832
+2% +$12.9M 0.78% 39
2015
Q4
$1.09B Buy
2,016,027
+93,894
+5% +$51M 1.07% 25
2015
Q3
$894M Buy
1,922,133
+189,407
+11% +$88.1M 0.92% 28
2015
Q2
$884M Buy
+1,732,726
New +$884M 0.81% 35